Onsdag 8 Juli | 20:37:57 Europe / Stockholm
Svenska | English
Kursutveckling under dagen för detta pressmeddelande (SEK).
Likviditet under dagen för detta pressmeddelande
Est. tid*
2026-10-22 07:00 Kvartalsrapport 2026-Q3
2026-07-14 07:00 Kvartalsrapport 2026-Q2
2026-05-20 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2026-05-19 - Årsstämma
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-05 - Bokslutskommuniké 2025
2025-10-23 - Kvartalsrapport 2025-Q3
2025-07-15 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2025-05-15 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-06 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-16 - Kvartalsrapport 2024-Q2
2024-05-15 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2024-05-14 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-08 - Bokslutskommuniké 2023
2023-10-27 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-05-08 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2023-05-05 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-09 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-02 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2022-04-29 - Årsstämma
2022-04-27 - Kvartalsrapport 2022-Q1
2022-02-10 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-29 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2021-04-28 - Årsstämma
2021-04-22 - Kvartalsrapport 2021-Q1
2021-02-04 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-13 - Kvartalsrapport 2020-Q2
2020-05-13 - Kvartalsrapport 2020-Q1
2020-04-29 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2020-04-28 - Årsstämma
2020-02-05 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-08 - Kvartalsrapport 2019-Q2
2019-05-16 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2019-05-15 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-07 - Bokslutskommuniké 2018
2018-11-06 - Kvartalsrapport 2018-Q3
2018-08-08 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2018-05-16 - Årsstämma
2018-05-08 - Kvartalsrapport 2018-Q1
2018-02-06 - Bokslutskommuniké 2017
2017-11-09 - Kvartalsrapport 2017-Q3
2017-08-10 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2017-05-18 - Årsstämma
2017-05-04 - Kvartalsrapport 2017-Q1
2017-02-09 - Bokslutskommuniké 2016
2016-11-10 - Kvartalsrapport 2016-Q3
2016-08-11 - Kvartalsrapport 2016-Q2
2016-05-20 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2016-05-19 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-12 - Kvartalsrapport 2015-Q3
2015-08-13 - Kvartalsrapport 2015-Q2
2015-05-22 - X-dag ordinarie utdelning BACTI B 0.00 SEK
2015-05-21 - Årsstämma
2015-05-12 - Kvartalsrapport 2015-Q1
2015-02-19 - Bokslutskommuniké 2014
2014-11-14 - Analytiker möte 2014
2014-11-14 - Kvartalsrapport 2014-Q3
2014-08-15 - Kvartalsrapport 2014-Q2
LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Bactiguard är ett globalt medicinteknikbolag som förebygger vårdrelaterade infektioner orsakade av medicintekniska produkter. Teknologin baseras på ett ultratunt ädelmetallytskikt som förebygger mikrobiell adhesion och bildande av biofilm. Bactiguard verkar genom licenssamarbeten med MedTech-företag som tillämpar teknologin på sina medicintekniska produkter. Bolaget har även en portfölj med sårvårdsprodukter. Bactiguard har huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Bactiguard Holding AB’s Annual and Sustainability Report 2024

2025-04-17 07:00:00
The Annual and Sustainably Report 2024 for Bactiguard Holding AB (publ) is now available at ir.bactiguard.com/

In 2024, Bactiguard completed the strategic shift needed to enable the company to be the premier choice for both current and future partners. This transformation delivered positive financial results and positioned Bactiguard for growth. The company achieved EBITDA profitability, which was a core commitment to its shareholders, along with positive cash flow from operating activities. Reaching these milestones marks a significant achievement, allowing Bactiguard to further develop its business and infection prevention technology platform. Most importantly, it validated the strength of the company’s business model and license-focused strategy.

“Through our license-focused strategy, we strive to be the premier partner for leading MedTech companies by delivering our knowledge and capabilities to enhance partner medical devices. Continuously strengthening our core competences remains essential to deepening partnerships and is a top priority for us also going forward. The synergies are clear – driving positive outcomes for our license partners also benefits Bactiguard, healthcare providers, and patients alike.” Christine Lind comments in his CEO statement.

Read more in Bactiguard Holding AB’s Annual and Sustainability Report 2024 here

Bactiguard Holding AB (publ) is obliged to make this information public under the Securities Markets Act. The information was submitted for publication at 07.00 CET on 17 April 2025.

For more information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communication & Investor Relations +46 708 550 356

About Bactiguard
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. The company also has a portfolio of wound management products. Bactiguard is headquartered in Stockholm and listed on Nasdaq Stockholm.

Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn

Källa Cision
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Företag
Pressmeddelanden